These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9432697)

  • 21. Zidovudine therapy and myopathies associated with human immunodeficiency virus infection.
    Chariot P; Ruet E; Gherardi R
    Ann Neurol; 1994 Feb; 35(2):247-8. PubMed ID: 8109910
    [No Abstract]   [Full Text] [Related]  

  • 22. Physical signs for the general dental practitioner. Case 49. Zidovudine (AZT or Retrovir) treatment.
    Bain S
    Dent Update; 2007 Nov; 34(9):596. PubMed ID: 18087932
    [No Abstract]   [Full Text] [Related]  

  • 23. Tolerability of postexposure prophylaxis with zidovudine, lamivudine, and nelfinavir for human immunodeficiency virus infection.
    Rabaud C; Bevilacqua S; Beguinot I; Dorvaux V; Schuhmacher H; May T; Canton P
    Clin Infect Dis; 2001 May; 32(10):1494-5. PubMed ID: 11317252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experiences with antiretroviral combination therapy].
    Justesen US; Mygind LH; Pedersen SS; Pedersen C
    Ugeskr Laeger; 1999 Mar; 161(12):1747-51. PubMed ID: 10210973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [HIV post-exposure prophylaxis after sexual risk contact].
    Battegay M; Zimmerli W
    Schweiz Med Wochenschr; 1999 Feb; 129(8):311-3. PubMed ID: 10189667
    [No Abstract]   [Full Text] [Related]  

  • 26. [Reducing perinatal transmission by antiretroviral therapy].
    Schmied B
    Wien Med Wochenschr; 1998; 148(23-24):550-5. PubMed ID: 10189685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acyclovir in combination with zidovudine does not prolong survival in advanced HIV disease.
    Erbelding EJ; Chaisson RE; Gallant JE; Moore RD
    Antivir Ther; 1997 Apr; 2(2):71-7. PubMed ID: 11322278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zidovudine + lamivudine: new preparation. Fewer tablets required.
    Prescrire Int; 1999 Apr; 8(40):39-40. PubMed ID: 10848057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mitochondrial toxicity: a case of palpebral ptosis in a woman infected by HIV and treated with HAART including zidovudine].
    Zannou DM; Azon-Kouanou A; Bashi BJ; Gougounon A; Zinsou R; Adé G; Houngbè F
    Bull Soc Pathol Exot; 2009 May; 102(2):97-8. PubMed ID: 19583030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preventable zidovudine overdose during postnatal prophylaxis in healthy children born to HIV-1-positive mothers.
    Chiappini E; Galli L; Gabiano C; Gattinara GC; Martino A; Scolfaro C; de Martino M
    AIDS; 2008 Jan; 22(2):316-7. PubMed ID: 18097238
    [No Abstract]   [Full Text] [Related]  

  • 31. [Rapid development of anemia in a HIV-positive patient with alpha-thalassemia after zidovudine therapy].
    Altinbaş A; Ozkaya G; Büyükaşik Y; Unal S
    Mikrobiyol Bul; 2007 Jul; 41(3):473-6. PubMed ID: 17933262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AVANTI 1: randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus loviride in HIV-infected antiretroviral-naive patients. AVANTI Study Group.
    Gatell J; Lange J; Gartland M
    Antivir Ther; 1999; 4(2):79-86. PubMed ID: 10682152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethical issues for perinatal HIV trials in developing countries.
    Phanuphak P; Vermund SH
    Pediatr AIDS HIV Infect; 1996 Aug; 7(4):236-8. PubMed ID: 11361714
    [No Abstract]   [Full Text] [Related]  

  • 34. [Anemia, neutropenia and thrombocytopenia: hematological findings and HIV].
    Wolf K; Tichelli A; Battegay M
    Praxis (Bern 1994); 2001 Oct; 90(41):1775-9. PubMed ID: 11692792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dilated cardiomyopathy in an adult human immunodeficiency virus type 1-positive patient treated with a zidovudine-containing antiretroviral regimen.
    Tanuma J; Ishizaki A; Gatanaga H; Kikuchi Y; Kimura S; Hiroe M; Oka S
    Clin Infect Dis; 2003 Oct; 37(7):e109-11. PubMed ID: 13130421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy.
    Parsonage MJ; Wilkins EG; Snowden N; Issa BG; Savage MW
    HIV Med; 2005 Sep; 6(5):341-6. PubMed ID: 16156882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of antiretroviral therapy on hepatitis C viraemia in HIV-infected patients.
    Bravo R; Soriano V; García-Samaniego J; Gómez-Cano M; González-Lahoz J; Altisent C; Ruiz I
    Antivir Ther; 1996 Aug; 1(3):194. PubMed ID: 11322254
    [No Abstract]   [Full Text] [Related]  

  • 38. [Lactic acidosis and hepatic mitochondrial changes during a treatment with zidovudine].
    Charton-Bain MC; Flamant M; Aubertin JM; Belair MF; Gilquin J; Kazatchkine M; Bruneval P
    Gastroenterol Clin Biol; 1997; 21(12):979-81. PubMed ID: 9587562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protease inhibitor combination.
    AIDS Patient Care STDS; 1996 Feb; 10(1):50. PubMed ID: 11361664
    [No Abstract]   [Full Text] [Related]  

  • 40. Interleukin-2 in combination with zidovudine and didanosine is able to maintain high levels of CD4 cells and undetectable HIV viraemia.
    Simonelli C; Zanussi S; Comar M; Vaccher E; Giacca M; De Paoli P; Tirelli U
    AIDS; 1998 Jan; 12(1):112-3. PubMed ID: 9456263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.